Bluejay Diagnostics Inc (NASDAQ: BJDX) kicked off on Monday, up 13.83% from the previous trading day, before settling in for the closing price of $0.09. Over the past 52 weeks, BJDX has traded in a range of $0.08-$38.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.00%. While this was happening, its average annual earnings per share was recorded N/A. With a float of $16.47 million, this company’s outstanding shares have now reached $16.55 million.
Let’s determine the extent of company efficiency that accounts for 10 employees. In terms of profitability, gross margin is 69.97%, operating margin of -624.55%, and the pretax margin is -648.92%.
Bluejay Diagnostics Inc (BJDX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Bluejay Diagnostics Inc is 0.49%, while institutional ownership is 1.13%. The most recent insider transaction that took place on Dec 13 ’23, was worth 1,535. In this transaction Director of this company bought 500 shares at a rate of $3.07, taking the stock ownership to the 1,500 shares. Before that another transaction happened on Dec 13 ’23, when Company’s President and CEO bought 500 for $3.27, making the entire transaction worth $1,635. This insider now owns 28,526 shares in total.
Bluejay Diagnostics Inc (BJDX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2023, the organization reported -19.2 earnings per share (EPS), lower than consensus estimate (set at -9.6) by -9.6. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Bluejay Diagnostics Inc (NASDAQ: BJDX) Trading Performance Indicators
Take a look at Bluejay Diagnostics Inc’s (BJDX) current performance indicators. Last quarter, stock had a quick ratio of 4.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -44.55
Technical Analysis of Bluejay Diagnostics Inc (BJDX)
Looking closely at Bluejay Diagnostics Inc (NASDAQ: BJDX), its last 5-days average volume was 7.01 million, which is a jump from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 26.41%. Additionally, its Average True Range was 0.02.
During the past 100 days, Bluejay Diagnostics Inc’s (BJDX) raw stochastic average was set at 0.40%, which indicates a significant decrease from 44.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.97% in the past 14 days, which was lower than the 187.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1705, while its 200-day Moving Average is $3.4059. However, in the short run, Bluejay Diagnostics Inc’s stock first resistance to watch stands at $0.1188. Second resistance stands at $0.1306. The third major resistance level sits at $0.1445. If the price goes on to break the first support level at $0.0931, it is likely to go to the next support level at $0.0792. Now, if the price goes above the second support level, the third support stands at $0.0674.
Bluejay Diagnostics Inc (NASDAQ: BJDX) Key Stats
The company with the Market Capitalisation of 1.77 million has total of 336K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -9,950 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,480 K.
